Secondary stroke prevention—personalized antiplatelet therapy

被引：0
|
作者：
David Tanne
机构：
[1] Sagol Neuroscience Center,
[2] Chaim Sheba Medical Center and Sackler Faculty of Medicine,undefined
[3] Tel Aviv University,undefined
来源：
Nature Reviews Neurology | 2012年 / 8卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
High platelet reactivity persists in many patients receiving antiplatelet therapy for secondary prevention of ischaemic stroke. Patient-tailored antiplatelet therapy, guided by platelet function tests, is an appealing approach for prevention of recurrent vascular events. However, a recent study has demonstrated that this strategy is associated with worse clinical outcomes.
引用
收藏
页码：536 / 537
页数：1
相关论文
共 50 条
12345